Laboratory Products & Services Outsourcing Market

Laboratory Products & Services Outsourcing Market Size, Share & Trends Analysis Report By Type (Products, Services), By Technology (Molecular Diagnostics, Immunoassays), By End Use, By Region, And Segment Forecasts

Published Date: August - 2025 | Publisher: MIR | No of Pages: 240 | Industry: healthcare | Format: Report available in PDF / Excel Format

View Details Download Free Sample Ask for Discount Request Customization
Claim a Free Sample

Get a preview with key statistics, projections, and trends for this report. Ideal for quick insights.

Send Me a Sample

Need full access?

Purchase Report
Contact Our Team

Chat on WhatsApp

+44 (0) 20 7606 4533

+1 (312) 932 0400

Contact via Email

Market Size & Trends

The size of the global laboratory products and services outsourcing market was USD 41.81 billion in 2024 and is expected to grow at a CAGR of 8.17% between 2025 and 2030. Market growth can be explained by an increase in the need to outsource product manufacturing and services to mitigate the rising cost burden.

Key Highlights

  • North America dominated the biggest market share of 38.99% in 2024
    The U.S. laboratory products and services outsourcing business is propelled owing to strong healthcare infrastructure
    On a type segment basis, the product segment led the laboratory products and services outsourcing market and generated 62.38% of the total revenue globally in 2024
    On a technology segment basis, the molecular diagnostics segment had the highest market share in 2024
    Based on end use segment, the market is divided into pharmaceutical & biotech firms, medical devices firms, CRO & CDMO, and others

In addition, increasing numbers of clinical trials, increase in adoption of personalized medicine and new therapeutics, increased R&D spending in the healthcare sector, and medical equipment technological advancements are some of the key market drivers. Increasing numbers of clinical trials are one of the drivers of market growth. For example, in December 2024, based on the figures released by WHO, clinical trials registered globally have consistently risen between 1999 and 2022, with dramatic increases in high-income countries. Of note, substantial increases in trial registrations have been reported for the Western Pacific region, specifically China and Japan. Disparities continue, as low-income countries still report much fewer trials, underlining continuing inequities in global clinical research.

Growing usage of personalized medicine and new therapeutics is driving market growth. In 2022, the U.S. Food and Drug Administration (FDA) approved 12 new personalized medicines, a milestone in widening targeted treatment, as per the article Personalized Medicine at FDA. The approval also encompassed expanding the usage of many current personalized therapies and adding two new siRNA therapies. Furthermore, the FDA provided essential guidance on the development of gene and cell therapies along with granting approval to use five such therapies. Besides this, the FDA's approval of a number of new diagnostic indications during 2022 enabled more specific and targeted treatment decisions for a host of health states, hence stimulating demand for laboratory products and services outsourcing.

Technological innovations like automation and AI-driven laboratory research are driving the growth of the market. For example, in April 2025, Precision for Medicine and PathAI partnered with each other to incorporate AI-fueled digital pathology solutions within clinical trials and biospecimen services. This collaboration will facilitate enhanced biomarker discovery and tissue analysis through sophisticated machine learning, and advance quality control, patient stratification, and data reliability. PathAI’s proprietary tools, such as AISight, will be incorporated into Precision’s laboratory and clinical workflows, offering deeper insights into complex tissue biology and accelerating drug development. The collaboration delivers unique, customized services exclusive to Precision for Medicine.

Report Coverage & Deliverables

  • Competitive benchmarking
  • Historical data & forecasts
  • Company revenue shares
  • Regional opportunities
  • Latest trends & dynamics

Opportunity Analysis

The laboratory products and services outsourcing industry is expected to witness significant growth opportunities driven by the increasing demand for cost-effective and efficient laboratory operations across pharmaceutical, biotechnology, and academic research sectors. The growing complexity and volume of scientific research, especially in genomics, proteomics, and drug discovery, encourages institutions and companies to outsource laboratory services to specialized providers with advanced infrastructure and skilled personnel.

In addition, rising R&D expenditures globally are boosting demand for outsourced laboratory products and services. Outsourcing laboratory services allows companies to focus on innovation while reducing overhead and capital expenditures on in-house lab operations. Furthermore, the outsourcing of laboratory consumables procurement is growing as procurement services become more streamlined and tech-enabled.

Impact of U.S. Tariffs on the Global Laboratory Products and Services Outsourcing Market

The US tariffs imposed in 2025 resulted in a severe impact on the global laboratory products and services outsourcing market. With import duties ranging from 20% to 25% on products from key suppliers such as China, Mexico, and Canada, the prices of crucial lab equipment, including analytical machines, medical plastics, and electronic components, have gone up, which put pressure on lab budgets, resulting in delays in purchasing equipment and project completion. Since no one is sure where the future of these tariffs will take them, suppliers are currently considering other markets and countries like India and Mexico are likely to become new hubs for laboratory equipment exports.

Laboratories and service providers are considering how they structure their supply chains to address these issues. Some are looking to relocate production near home to sidestep hefty tariffs, while others are investing in producing goods in their own nations to depend less on imports. The rising expenses and supply chain disruptions are also altering the way laboratories design clinical trials and studies, with some thinking of conducting trials in new places or via remote means to cut costs. U.S. tariffs are making the laboratory industry adapt rapidly, demonstrating how vital it is to think ahead and have various options in the current changing trade scenario. The industry is witnessing rapid expansion, fueled by the convergence of sophisticated technologies that optimize business processes and improve data accuracy in laboratory settings.

Cloud-based Laboratory Management Systems (LMS) provide centralized, real-time access to information, allowing effortless collaboration among geographically distributed teams. Robotic Process Automation (RPA) also optimizes workflows by automating routine tasks like sample handling, substantially increasing throughput while reducing human error. Moreover, contemporary data-sharing infrastructure allows seamless interoperability between laboratory instruments, software platforms, and client-facing systems. 

Market Concentration & Characteristics

The laboratory products and services outsourcing industry growth stage is medium and anticipated to accelerate in growth. Key drivers include technological advancements, evolving regulatory landscapes, and the globalization and outsourcing of product processes. These factors offer distinct advantages, allowing organizations to access specialized capabilities and optimize operational efficiency.

The outsourcing industry for laboratory products and services has a high level of innovation, with ongoing technological and process innovation. The innovations promote specialization and efficiency, which allow providers to deliver innovative solutions to address changing client demands and industry standards.

Regulations are highly influential in the market, impacting compliance needs, quality expectations, and entry barriers into the market. Compliance with regulatory structures informs operational models, service delivery, and strategic choices, affecting market dynamics and competitiveness.

The intensity of M&A activity in the market is high, with cyclical consolidation and strategic alliances reconfiguring the competitive landscape. M&A transactions are led by expansion into new markets, diversification of service offerings, and attempts to realize economies of scale. For example, during April 2025, Source BioScience UK Ltd, a leading industry provider of histopathology diagnostics and genomic services, said it had acquired Cambridge Clinical Laboratories (CCL), a top provider of clinical, customized healthcare testing services in Cambridge. The move bolsters the company's clinical diagnostics business by leveraging the CCL staff's expertise and new, state-of-the-art clinical lab facilities at Vision Park in Cambridge, providing accelerated testing services for preclinical and clinical research.

Market expansion of services is medium, with providers diversifying services to address changing client requirements and market needs. Expansion involves introducing new test methodologies, further analytical capacity, and geographic spread to address a wider base of clients. Besides, providers increasingly provide value-added services like consulting, regulatory support, and data analytics to differentiate themselves in the market.

The industry is undergoing extensive regional growth, as providers are strategically increasing their reach into new geographic locations. This growth enables them to access developing markets, take advantage of increased demand for lab services, and gain a larger client base. Furthermore, it also means greater proximity to clients, allowing for quicker response and more customized delivery of services.

Type Insights

Based on the type segment, the market is divided into products and services. Product segment led the laboratory products and services outsourcing market and comprised 62.38% of total revenue in 2024. The products segment entails equipment and disposables like test tubes and pipettes, reagents, chemicals, and other basic supplies required for performing experiments and analysis. Scientific development requires efficient and accurate laboratory procedures, driving the demand for general, analytical, clinical, support, and specialty equipment. Advanced instrumentation demand resulting from the need for accurate chemical analysis and medical diagnostics drives the segment's growth.

The service segment is expected to expand at the highest CAGR during the forecast period. The growing complexity of drug development techniques and the strict regulatory requirements are fueling the need for specialized skill and cutting-edge analytical facilities. Sub-categories such as ADME, PK, PD, Bioavailability, and Bioequivalence testing are essential for evaluating the safety and efficacy of pharmaceutical compounds, For instance, in May 2024, BioAgilytix entered into a partnership agreement with BBI Solutions OEM Limited (BBI) to integrate its bioanalytical testing services with BBI’s ability to produce high-quality antibody reagents for various testing purposes. This partnership is intended to improve the effectiveness of bioanalytical testing services for the pharmaceutical and biopharmaceutical sectors.

Technology Insights

Based on the technology segment, the molecular diagnostics segment held the highest market share in 2024. Molecular biology methods and personalized medicine strategies further increase the demand for molecular diagnostic services. Improvements in molecular diagnostic methods have transformed disease detection into rapid and accurate outcomes. For example, in April 2024, the TSX Universal Series ULT Freezers from Thermo Fisher Scientific were certified by ENERGY STAR. The freezers are designed to provide better performance, more precise temperature control, and quicker recovery times.

The immunoassays segment is expected to expand at the highest CAGR during the forecast period. Immunoassays provide high sensitivity and specificity and are useful tools for disease diagnosis and drug development processes. Technological innovations such as multiplexing and automation have transformed immunoassay platforms to allow concurrent analysis of several analytes in a single sample, cutting down on time and expenses. Multiplex immunoassays, such as Luminex bead-based assays and protein microarrays, provide high analytical precision in biomedical research and clinical diagnostics. New technologies such as organ-on-a-chip further improve multiplexing capacities, enabling concurrent analysis of biomarkers with high sensitivity and low user intervention.

End Use Insights

Based on the end use segment, the market is divided into pharmaceutical & biotech companies, medical device companies, CRO & CDMO, and others. Pharmaceutical and biotech companies ruled in 2024. The segment growth is attributed to their extensive R&D activities, complicated testing requirements, and stringent regulatory needs. These firms continuously invest in state-of-the-art laboratory equipment, consumables, and support services for expediting drug discovery, efficient clinical development, and quality assurance in all phases. Their requirement for high-precision equipment, reliable testing facilities, and ongoing technical support generates strong demand, making them the top drivers of market growth.

To get more details about this report, request a free sample copy

The segment of medical device companies is also anticipated to develop at the highest CAGR throughout the forecast period. The growth is primarily attributed to escalating innovation in diagnosis and therapy technology, heightened regulatory compliance needs, and expanding dependence on laboratory services for product development and validation. As their product lines expand with increasingly sophisticated and specialty devices, demand for advanced lab products and outsourced testing services is gaining momentum, especially in the biocompatibility testing, sterilization validation, and analytical support markets, driving further segment growth.

Regional Insights

North America was the market leader with a market share of 38.99% in 2024. There are a number of reasons, including technological innovation, rigorous regulatory standards, and growing demand for specialized services, which drive this optimistic market forecast. Moreover, the location of major pharmaceutical and biotechnology firms and high research and development intensity also drive market growth. For example, in March 2025, IQVIA Laboratories introduced Site Lab Navigator, a state-of-the-art platform that aims to automate laboratory functions in clinical trials with its groundbreaking e-Requisition system. Through this online solution, investigator sites can electronically manage lab requisitions and specimen handling and eliminate time-consuming and antiquated paper-based practices.

U.S. Laboratory Products and Services Outsourcing Market Trends
The U.S. laboratory products and services outsourcing industry is fueled as a result of strong healthcare infrastructure, advances in technology, highly qualified workforce, favorable regulatory environments, and the presence of pharmaceutical and biotechnology giants. The other driving factors include the rising need for laboratory special services and the increasing outsourcing of non-core functions among the healthcare sector, which further reinforced the U.S. leadership in the market. The nation's robust research and academic institutions, public-private partnerships, and growing emphasis on personalized care and clinical trials have also been major contributors. Additionally, contract research organizations continue to broaden service lines, drawing in greater outsourcing alliances.

Europe Laboratory Products and Services Outsourcing Market Trends
The European Laboratory products and services outsourcing market will grow substantially because of technological developments, changing regulatory environments, and rising demand for specialized services. European providers provide laboratory solutions in the form of testing, research, and consulting services, with heavy emphasis on innovation and quality. Higher R&D spending in the pharmaceutical, biotechnology, and chemical industries further enhances growth.

The laboratory products and services outsourcing market in Germany held the largest share in 2024 in Europe, owing to several trends shaping the landscape. Importance of precision medicine and personalized healthcare solutions, driving demand for specialized laboratory services designed for individual patient needs. Moreover, advancements in digitalization and automation are revolutionizing laboratory processes, leading to increased efficiency, accuracy, and cost-effectiveness.

The UK laboratory products and services outsourcing market is expected to expand during the forecast period. Technological innovations, rising demand for specialized services, and growing requirements for cost-effective services will be the driving factors for market growth. Moreover, partnerships among outsourcing providers and healthcare organizations and emphasis on innovation and quality will continue to drive market growth. With a robust healthcare infrastructure and trained workforce, the UK continues to be one of the prime drivers of the global laboratory outsourcing market, ready to grow and innovate further in the years to come.

Asia Pacific Laboratory Products and Services Outsourcing Market Trends
The Asia Pacific region is anticipated to expand at a CAGR of 8.73% during the forecast period. The Asia Pacific region demand for outsourcing laboratory products and services is fueled by cost benefits, access to skilled labor, increasing healthcare demands, and increasing pharmaceutical and biotechnology industries. Several companies are currently outsourcing lab services to India and China to reduce expenses, enhance efficiency, and capitalize on regional skills, especially clinical trials and R&D. Additionally, appropriate government policies, rich patient base, and growing investment in healthcare infrastructure make the region an attractive one for laboratory products and services outsourcing.

The laboratory products and services outsourcing market of China dominated the market in 2024 in the Asia Pacific region because of superior R&D infrastructure, adoption of superior technologies and presence of expertise is expected to enhance the growth of the nation's market. Secondly, the presence of cheap labor is one of the primary reasons for pharma companies from all over the world to outsource laboratory products and services in China. Further, firm support for scientific research, growing partnerships with international biotech and pharma companies, and the growth of CRO networks are driving the development of the market. China's strong supply chain and increasing focus on quality standards further reinforce its position as a dominant hub for outsourced laboratory solutions.

Japan's laboratory products and services outsourcing market is likely to grow during the forecast period as a result of increasing product development expenses, driving outsourcing to maximize costs. Additionally, ongoing technological innovation in innovative product development and changing regulatory scenarios are anticipated to drive market demand. Additionally, Japan's aging population and increased emphasis on precision medicine are driving demand for sophisticated laboratory testing and analytical services. The nation is also experiencing heightened collaboration between private laboratories and academic institutions, enhancing research and innovation capabilities. These are some of the factors driving the increased demand for efficient and consistent outsourced laboratory services.

The market for laboratory products and services outsourcing in India is expected to expand at the highest CAGR during the forecast period, driven by its huge pool of talent, strong infrastructure, supportive regulatory system, and surging demand for sophisticated laboratory testing and pharmaceutical research.

Latin America Laboratory Products and Services Outsourcing Market Trends
The Latin American market is expected to expand at a significant rate during the forecast period. The development of the region is due to rising demand for outsourced laboratory services fueled by the developing healthcare segment in the region, expanding research & development spending, and increasing use of next-generation technologies. Also, government support programs and regulatory changes encouraging innovation and foreign investment are also poised to drive market growth.

The Brazil laboratory products and services outsourcing market is expected to expand at a high CAGR during the forecast period. The huge and heterogeneous healthcare sector of the country, growing need for specialized laboratory services, rising investments in research and development, and encouraging government policies focusing on improving innovation and attracting foreign investments are fueling the market growth.

Key Laboratory Products And Services Outsourcing Company Insights

The key players functioning throughout the market aim to implement some strategic measures like service launches, mergers & acquisitions/joint ventures, mergers, partnerships & agreements, expansions, and others to enhance market presence & revenue and achieve competitive advantage, propelling market growth. For example, Quest Diagnostics, the leading diagnostic information services provider, in August 2024, made a deal to buy selected assets of University Hospitals' outreach laboratory services in Ohio to provide its superior diagnostic services in the state. Such alliances helped the company improve its operational effectiveness, quality maintenance, and support for low-cost healthcare.

Laboratory Products And Services Outsourcing Companies

The following are the leading companies in the laboratory products and services outsourcing market. These companies collectively hold the largest market share and dictate industry trends.

Recent Developments

  • In April 2025, Source BioScience UK Ltd. took over Cambridge Clinical Laboratories (CCL), a provider of clinical and personalized healthcare testing services. The strategic buyover was for increasing the diagnostic capacity of the company through the incorporation of CCL's state-of-the-art laboratory facilities, extending its end-to-end testing solutions for both clinical and research applications.

    In September 2023, Bio-Rad Laboratories, Inc., launched its PTC Tempo 384 Thermal Cyclers and PTC Tempo 48/48. These new instruments are engineered to simplify PCR applications in many fields such as translational and basic research, process development, and quality control.

    In July 2023, NAMSA acquired Clinical Research Institute, a Germany-based full service Contract Research Organization (CRO). The move was to extend company's contract service capabilities in Europe and other regions.

Laboratory Products And Services Outsourcing Market Report Scope

Report Attribute

Details

 Market size value in 2025

USD 45.32 billion

 Revenue forecast in 2030

USD 67.12 billion

 Growth rate

CAGR of 8.17% from 2025 to 2030

Actual data

2018 - 2024

Forecast period

2025 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, technology, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Thermo Fisher Scientific; Charles River Laboratories; Eurofins Scientific; Labcorp; Quest Diagnostics; Parexel International Corporation; Agilent Technologies; PerkinElmer; Bio-Rad Laboratories; SGS SA; Intertek Group plc Inc; WuXi AppTec, Inc

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Laboratory Products & Services Outsourcing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, MIR has segmented the global laboratory products and services outsourcing market report based on type, technology, end use and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Products

      • Equipment

        • General

        • Analytical

        • Clinical

        • Support

        • Specialty

      • Disposables

      • Others

    • Services

      • Pharmaceutical

        • Bioanalytical Testing

          • ADME

          • PK

          • PD

          • Bioavailability

          • Bioequivalence

          • Others

        • Method Development & Validation

          • Extractable & Leachable

          • Impurity Method

          • Technical Consulting

          • Others

        • Stability Testing

          • Drug Substance

          • Stability Indicating Method Validation

          • Accelerated Stability Testing

          • Photostability Testing

          • Others

        • Others

    • Medical Device

      • Biocompatibility Tests

      • Chemistry Test

      • Microbiology & Sterility Testing

      • Others

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)

    • Immunoassays

    • Molecular Diagnostics

    • Microbiology

    • Clinical Chemistry

    • Flow Cytometry

    • Mass Spectroscopy

    • Chromatography

    • Others

  • End Use Outlook (Revenue, USD Million, 2018 - 2030)

    • Pharmaceutical & Biotech Companies

    • Medical Device Companies

    • CRO & CDMO

    • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions

The global laboratory products and services outsourcing market size was estimated at USD 41.81 billion in 2024 and is expected to reach USD 45.32 billion in 2025.

The global laboratory products and services outsourcing market is expected to grow at a compound annual growth rate of 8.17% from 2025 to 2030 to reach USD 67.12 billion by 2030.

North America region dominated the laboratory products and services outsourcing market with a share of 37.99% in 2024. This is attributable to high number of clinical trials, advanced healthcare infrastructure, stringent regulatory guidelines, and constant research and development initiatives.

Some key players operating in the laboratory products and services outsourcing market include Thermo Fisher Scientific, Charles River Laboratories, Eurofins Scientific, Labcorp, Quest Diagnostics, Parexel International Corporation, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, SGS SA, Intertek Group plc Inc, WuXi AppTec, Inc.

Key factors that are driving the market growth include adoption of personalized medicine, increasing outsourcing trends among pharmaceutical companies, and surge in number of clinical trials among others.

Related Reports

Table of Content

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Regional Scope
                        1.1.2. Estimates and Forecast Timeline
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                    1.5. Information or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Validation
                        1.6.1. Region Wise Market: Base Estimates
                        1.6.2. Global Market: CAGR Calculation
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis (Model 1)
                        1.7.2. Value-Chain-Based Sizing & Forecasting (Model 2)
                        1.7.3. QFD Model Sizing & Forecasting (Model 3)
                        1.7.4. Bottom-Up Approach (Model 4)
                    1.8. List of Secondary Sources
                    1.9. List of Abbreviations
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Laboratory Products and Services Outsourcing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Pricing Model Analysis
                    3.4. Technology Landscape
                    3.5. Business Model Analysis
                    3.6. Clinical Trial Volume Analysis, 2024
                        3.6.1. Total Number of Clinical Trials, by Region (2024)
                        3.6.2. Total Number of Clinical Trials, by Phase (2024)
                        3.6.3. Total Number of Clinical Trials, by Study Design (2024)
                        3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
                    3.7. Laboratory Products And Services Outsourcing Market: Analysis Tools
                        3.7.1. Porter’s Five Forces Analysis
                        3.7.2. PESTEL by SWOT Analysis
                        3.7.3. COVID-19 Impact Analysis
Chapter 4. Laboratory Products and Services Outsourcing Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
                    4.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Type, 2018 - 2030 (USD Million)
                    4.4. Products
                        4.4.1. Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.4.2. Equipment
                            4.4.2.1. Equipment Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.4.2.2. General
                                4.4.2.2.1. General Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.4.2.3. Analytical
                                4.4.2.3.1. Analytical Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.4.2.4. Clinical
                                4.4.2.4.1. Clinical Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.4.2.5. Support
                                4.4.2.5.1. Support Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.4.2.6. Specialty
                                4.4.2.6.1. Specialty Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.4.3. Disposables
                            4.4.3.1. Disposables Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.4.4. Others
                            4.4.4.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
                    4.5. Services
                        4.5.1. Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.5.2. Pharmaceutical
                            4.5.2.1. Pharmaceutical Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.2.2. Bioanalytical Testing
                                4.5.2.2.1. Bioanalytical Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.2. ADME
                                    4.5.2.2.2.1. ADME Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.3. PK
                                    4.5.2.2.3.1. PK Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.4. PD
                                    4.5.2.2.4.1. PD Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.5. Bioavailability
                                    4.5.2.2.5.1. Bioavailability Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.6. Bioequivalence
                                    4.5.2.2.6.1. Bioequivalence Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.2.7. Others
                                    4.5.2.2.7.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.2.3. Method Development & Validation
                                4.5.2.3.1. Method Development & Validation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.3.2. Extractable & Leachable
                                    4.5.2.3.2.1. Extractable & Leachable Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.3.3. Impurity Method
                                    4.5.2.3.3.1. Impurity Method Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.3.4. Technical Consulting
                                    4.5.2.3.4.1. Technical Consulting Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.3.5. Others
                                    4.5.2.3.5.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.2.4. Stability Testing
                                4.5.2.4.1. Stability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.4.2. Drug Substance
                                    4.5.2.4.2.1. Drug substance Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.4.3. Stability Indicating Method Validation
                                    4.5.2.4.3.1. Stability Indicating Method Validation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.4.4. Accelerated Stability Testing
                                    4.5.2.4.4.1. Accelerated Stability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.4.5. Photostability Testing
                                    4.5.2.4.5.1. Photostability Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                                4.5.2.4.6. Others
                                    4.5.2.4.6.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.5.3. Others
                            4.5.3.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
                        4.5.4. Medical Device
                            4.5.4.1. Medical Device Market Estimates and Forecast, 2018 -- 2030 (USD Million)
                            4.5.4.2. Biocompatibility Tests
                                4.5.4.2.1. Biocompatibility Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.4.3. Chemistry Test
                                4.5.4.3.1. Chemistry Test Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.4.4. Microbiology & Sterility Testing
                                4.5.4.4.1. Microbiology & Sterility Testing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                            4.5.4.5. Others
                                4.5.4.5.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 5. Laboratory Products and Services Outsourcing Market: Technology Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
                    5.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
                    5.4. Immunoassays
                        5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.5. Molecular Diagnostics
                        5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.6. Microbiology
                        5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.7. Clinical Chemistry
                        5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.8. Flow Cytometry
                        5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.9. Mass Spectroscopy
                        5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.10. Chromatography
                        5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    5.11. Others
                        5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 6. Laboratory Products and Services Outsourcing Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
                    6.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    6.4. Pharmaceutical & Biotech Companies
                        6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    6.5. Medical Device Companies
                        6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    6.6. CRO & CDMO
                        6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    6.7. Others
                        6.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 7. Laboratory Products and Services Outsourcing Market: Regional Estimates & Trend Analysis by Type, Technology & End Use
                    7.1. Regional Market Dashboard
                    7.2. Global Regional Market Snapshot
                    7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
                    7.4. North America
                        7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.4.2. U.S.
                            7.4.2.1. Key Country Dynamics
                            7.4.2.2. Competitive Scenario
                            7.4.2.3. Regulatory Scenario
                            7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.4.3. Canada
                            7.4.3.1. Key Country Dynamics
                            7.4.3.2. Competitive Scenario
                            7.4.3.3. Regulatory Scenario
                            7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.4.4. Mexico
                            7.4.4.1. Key Country Dynamics
                            7.4.4.2. Competitive Scenario
                            7.4.4.3. Regulatory Scenario
                            7.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    7.5. Europe
                        7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.2. UK
                            7.5.2.1. Key Country Dynamics
                            7.5.2.2. Competitive Scenario
                            7.5.2.3. Regulatory Scenario
                            7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.3. Germany
                            7.5.3.1. Key Country Dynamics
                            7.5.3.2. Competitive Scenario
                            7.5.3.3. Regulatory Scenario
                            7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.4. France
                            7.5.4.1. Key Country Dynamics
                            7.5.4.2. Competitive Scenario
                            7.5.4.3. Regulatory Scenario
                            7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.5. Italy
                            7.5.5.1. Key Country Dynamics
                            7.5.5.2. Competitive Scenario
                            7.5.5.3. Regulatory Scenario
                            7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.6. Spain
                            7.5.6.1. Key Country Dynamics
                            7.5.6.2. Competitive Scenario
                            7.5.6.3. Regulatory Scenario
                            7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.7. Denmark
                            7.5.7.1. Key Country Dynamics
                            7.5.7.2. Competitive Scenario
                            7.5.7.3. Regulatory Scenario
                            7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.8. Sweden
                            7.5.8.1. Key Country Dynamics
                            7.5.8.2. Competitive Scenario
                            7.5.8.3. Regulatory Scenario
                            7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.5.9. Norway
                            7.5.9.1. Key Country Dynamics
                            7.5.9.2. Competitive Scenario
                            7.5.9.3. Regulatory Scenario
                            7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    7.6. Asia Pacific
                        7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.2. China
                            7.6.2.1. Key Country Dynamics
                            7.6.2.2. Competitive Scenario
                            7.6.2.3. Regulatory Scenario
                            7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.3. Japan
                            7.6.3.1. Key Country Dynamics
                            7.6.3.2. Competitive Scenario
                            7.6.3.3. Regulatory Scenario
                            7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.4. India
                            7.6.4.1. Key Country Dynamics
                            7.6.4.2. Competitive Scenario
                            7.6.4.3. Regulatory Scenario
                            7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.5. Australia
                            7.6.5.1. Key Country Dynamics
                            7.6.5.2. Competitive Scenario
                            7.6.5.3. Regulatory Scenario
                            7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.6. South Korea
                            7.6.6.1. Key Country Dynamics
                            7.6.6.2. Competitive Scenario
                            7.6.6.3. Regulatory Scenario
                            7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.6.7. Thailand
                            7.6.7.1. Key Country Dynamics
                            7.6.7.2. Competitive Scenario
                            7.6.7.3. Regulatory Scenario
                            7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    7.7. Latin America
                        7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.7.2. Brazil
                            7.7.2.1. Key Country Dynamics
                            7.7.2.2. Competitive Scenario
                            7.7.2.3. Regulatory Scenario
                            7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.7.3. Argentina
                            7.7.3.1. Key Country Dynamics
                            7.7.3.2. Competitive Scenario
                            7.7.3.3. Regulatory Scenario
                            7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                    7.8. MEA
                        7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.8.2. South Africa
                            7.8.2.1. Key Country Dynamics
                            7.8.2.2. Competitive Scenario
                            7.8.2.3. Regulatory Scenario
                            7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.8.3. Saudi Arabia
                            7.8.3.1. Key Country Dynamics
                            7.8.3.2. Competitive Scenario
                            7.8.3.3. Regulatory Scenario
                            7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.8.4. UAE
                            7.8.4.1. Key Country Dynamics
                            7.8.4.2. Competitive Scenario
                            7.8.4.3. Regulatory Scenario
                            7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
                        7.8.5. Kuwait
                            7.8.5.1. Key Country Dynamics
                            7.8.5.2. Competitive Scenario
                            7.8.5.3. Regulatory Scenario
                            7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Service Heat Map Analysis (a comparative analysis of the players together)
                    8.3. Company Profiles
                        8.3.1. Thermo Fisher Scientific
                            8.3.1.1. Company Overview
                            8.3.1.2. Financial Performance
                            8.3.1.3. Product/Service Benchmarking
                            8.3.1.4. Strategic Initiatives
                        8.3.2. Charles River Laboratories
                            8.3.2.1. Company Overview
                            8.3.2.2. Financial Performance
                            8.3.2.3. Product/Service Benchmarking
                            8.3.2.4. Strategic Initiatives
                        8.3.3. Eurofins Scientific
                            8.3.3.1. Company Overview
                            8.3.3.2. Financial Performance
                            8.3.3.3. Product/Service Benchmarking
                            8.3.3.4. Strategic Initiatives
                        8.3.4. Labcorp
                            8.3.4.1. Company Overview
                            8.3.4.2. Financial Performance
                            8.3.4.3. Product/Service Benchmarking
                            8.3.4.4. Strategic Initiatives
                        8.3.5. Quest Diagnostics
                            8.3.5.1. Company Overview
                            8.3.5.2. Financial Performance
                            8.3.5.3. Product/Service Benchmarking
                            8.3.5.4. Strategic Initiatives
                        8.3.6. Parexel International Corporation
                            8.3.6.1. Company Overview
                            8.3.6.2. Financial Performance
                            8.3.6.3. Product/Service Benchmarking
                            8.3.6.4. Strategic Initiatives
                        8.3.7. Agilent Technologies
                            8.3.7.1. Company Overview
                            8.3.7.2. Financial Performance
                            8.3.7.3. Product/Service Benchmarking
                            8.3.7.4. Strategic Initiatives
                        8.3.8. PerkinElmer
                            8.3.8.1. Company Overview
                            8.3.8.2. Financial Performance
                            8.3.8.3. Product/Service Benchmarking
                            8.3.8.4. Strategic Initiatives
                        8.3.9. Bio-Rad Laboratories
                            8.3.9.1. Company Overview
                            8.3.9.2. Financial Performance
                            8.3.9.3. Product/Service Benchmarking
                            8.3.9.4. Strategic Initiatives
                        8.3.10. SGS SA
                            8.3.10.1. Company Overview
                            8.3.10.2. Financial Performance
                            8.3.10.3. Product/Service Benchmarking
                            8.3.10.4. Strategic Initiatives
                        8.3.11. Intertek Group plc
                            8.3.11.1. Company Overview
                            8.3.11.2. Financial Performance
                            8.3.11.3. Product/Service Benchmarking
                            8.3.11.4. Strategic Initiatives
                        8.3.12. WuXi AppTec Co., Ltd.
                            8.3.12.1. Company Overview
                            8.3.12.2. Financial Performance
                            8.3.12.3. Product/Service Benchmarking
                            8.3.12.4. Strategic Initiatives

 

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 4 Global Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 5 Global Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Laboratory Products and Services Outsourcing, by Region, 2018 - 2030 (USD Million)
Table 7 North America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
Table 8 North America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 9 North America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 10 North America Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 12 U.S. Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 13 U.S. Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 15 Canada Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 16 Canada Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 17 Mexico Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 18 Mexico Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 19 Mexico Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 20 Europe Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 22 Europe Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 23 Europe Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 24 Germany Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 25 Germany Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 26 Germany Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 27 UK Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 28 UK Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 29 UK Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 30 France Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 31 France Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 32 France Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 33 Italy Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 34 Italy Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 35 Italy Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 36 Spain Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 37 Spain Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 38 Spain Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 39 Denmark Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 40 Denmark Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 41 Denmark Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 42 Sweden Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 43 Sweden Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 44 Sweden Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 45 Norway Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 46 Norway Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 47 Norway Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 52 China Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 53 China Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 54 China Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 55 Japan Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 56 Japan Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 57 Japan Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 58 India Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 59 India Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 60 India Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 61 South Korea Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 62 South Korea Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 63 South Korea Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 64 Australia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 65 Australia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 66 Australia Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 68 Thailand Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 69 Thailand Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 72 Latin America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 73 Latin America Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 74 Brazil Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 75 Brazil Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 76 Brazil Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 77 Argentina Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 78 Argentina Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 79 Argentina Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 84 South Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 85 South Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 86 South Africa Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 90 UAE Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 91 UAE Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 92 UAE Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)
Table 93 Kuwait Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
Table 95 Kuwait Laboratory Products and Services Outsourcing, by End Use, 2018 - 2030 (USD Million)

 

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Laboratory Products and Services Outsourcing, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Laboratory Products and Services Outsourcing, for Product, 2018 - 2030 (USD Million)
Fig. 13 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
Fig. 14 Global Laboratory Products and Services Outsourcing, for General, 2018 - 2030 (USD Million)
Fig. 15 Global Laboratory Products and Services Outsourcing, for Analytical, 2018 - 2030 (USD Million)
Fig. 16 Global Laboratory Products and Services Outsourcing, for Clinical, 2018 - 2030 (USD Million)
Fig. 17 Global Laboratory Products and Services Outsourcing, for Support, 2018 - 2030 (USD Million)
Fig. 18 Global Laboratory Products and Services Outsourcing, for Specialty, 2018 - 2030 (USD Million)
Fig. 19 Global Laboratory Products and Services Outsourcing, for Disposables, 2018 - 2030 (USD Million)
Fig. 20 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 21 Global Laboratory Products and Services Outsourcing, for Services, 2018 - 2030 (USD Million)
Fig. 22 Global Laboratory Products and Services Outsourcing, for Pharmaceutical, 2018 - 2030 (USD Million)
Fig. 23 Global Laboratory Products and Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
Fig. 24 Global Laboratory Products and Services Outsourcing, for ADME, 2018 - 2030 (USD Million)
Fig. 25 Global Laboratory Products and Services Outsourcing, for PK, 2018 - 2030 (USD Million)
Fig. 26 Global Laboratory Products and Services Outsourcing, for PD, 2018 - 2030 (USD Million)
Fig. 27 Global Laboratory Products and Services Outsourcing, for Bioavailability, 2018 - 2030 (USD Million)
Fig. 28 Global Laboratory Products and Services Outsourcing, for Bioequivalence, 2018 - 2030 (USD Million)
Fig. 29 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 30 Global Laboratory Products and Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
Fig. 31 Global Laboratory Products and Services Outsourcing, for Extractable and Leachable, 2018 - 2030 (USD Million)
Fig. 32 Global Laboratory Products and Services Outsourcing, for Impurity Method, 2018 - 2030 (USD Million)
Fig. 33 Global Laboratory Products and Services Outsourcing, for Technical Consulting, 2018 - 2030 (USD Million)
Fig. 34 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 35 Global Laboratory Products and Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
Fig. 36 Global Laboratory Products and Services Outsourcing, for Drug Substance, 2018 - 2030 (USD Million)
Fig. 37 Global Laboratory Products and Services Outsourcing, for Stability Indicating Method Validation, 2018 - 2030 (USD Million)
Fig. 38 Global Laboratory Products and Services Outsourcing, for Accelerated Stability Testing, 2018 - 2030 (USD Million)
Fig. 39 Global Laboratory Products and Services Outsourcing, for Photostability Testing, 2018 - 2030 (USD Million)
Fig. 40 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 41 Global Laboratory Products and Services Outsourcing, for Medical Device, 2018 - 2030 (USD Million)
Fig. 42 Global Laboratory Products and Services Outsourcing, for Biocompatibility Tests, 2018 - 2030 (USD Million)
Fig. 43 Global Laboratory Products and Services Outsourcing, for Chemistry Test, 2018 - 2030 (USD Million)
Fig. 44 Global Laboratory Products and Services Outsourcing, for Microbiology & Sterility Testing, 2018 - 2030 (USD Million)
Fig. 45 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 46 Global Laboratory Products and Services Outsourcing, for Immunoassays, 2018 - 2030 (USD Million)
Fig. 47 Global Laboratory Products and Services Outsourcing, for Molecular Diagnostics, 2018 - 2030 (USD Million)
Fig. 48 Global Laboratory Products and Services Outsourcing, for Microbiology, 2018 - 2030 (USD Million)
Fig. 49 Global Laboratory Products and Services Outsourcing, for Clinical Chemistry, 2018 - 2030 (USD Million)
Fig. 50 Global Laboratory Products and Services Outsourcing, for Flow Cytometry, 2018 - 2030 (USD Million)
Fig. 51 Global Laboratory Products and Services Outsourcing, for Chromatography, 2018 - 2030 (USD Million)
Fig. 52 Global Laboratory Products and Services Outsourcing, for Mass Spectroscopy, 2018 - 2030 (USD Million)
Fig. 53 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 54 Global Laboratory Products and Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
Fig. 55 Global Laboratory Products and Services Outsourcing, for Pharmaceutical & Biotech Companies, 2018 - 2030 (USD Million)
Fig. 56 Global Laboratory Products and Services Outsourcing, for CRO & CDMO, 2018 - 2030 (USD Million)
Fig. 57 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
Fig. 58 Regional Outlook, 2024 & 2030
Fig. 59 North America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 U.S. Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Canada Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Mexico Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Europe Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Germany Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 UK Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 France Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 Italy Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Spain Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 Denmark Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Sweden Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Norway Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Asia Pacific Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Japan Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 China Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 75 India Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Australia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 77 South Korea Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Thailand Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 79 Latin America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 Brazil Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Argentina Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 82 Middle East and Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 South Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 84 Saudi Arabia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 UAE Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 86 Kuwait Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Laboratory Products And Services Outsourcing Companies:

The following are the leading companies in the laboratory products and services outsourcing market. These companies collectively hold the largest market share and dictate industry trends.